Yale New Haven — New Haven, Connecticut

Yale New Haven is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Clinical Trials Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Yale New Haven has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Peripheral Arterial Hemorrhage, Trauma, GI Bleed.

Sponsors: Medtronic Endovascular, CareDx, Penumbra Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale New Haven?

Yale New Haven has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale New Haven conducted?

Yale New Haven has 5 clinical trials on record, with 3 currently active. Their work covers Peripheral Arterial Hemorrhage, Trauma, GI Bleed.

Is Yale New Haven accredited by Crixeo Clinical Trials?

Yale New Haven has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.